JP Morgan Chase
PTCT icon

JP Morgan Chase’s PTC Therapeutics PTCT Stock Holding History

JP Morgan Chase’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.77M Hold
27,000
– – ﹤0.01% 4202
2025
Q4 		$2.05M Buy
+27,000
New +$1.96M ﹤0.01% 4052
2025
Q2 		– Sell
-84,000
Closed -$4.28M – 7519
2025
Q1 		$4.28M Buy
84,000
+30,000
+56% +$1.5M ﹤0.01% 3288
2024
Q4 		$2.44M Buy
+54,000
New +$2.31M ﹤0.01% 3995
2022
Q3 		– Sell
-18,500
Closed -$741K – 6774
2022
Q2 		$741K Buy
+18,500
New +$649K ﹤0.01% 4300
2021
Q3 		– Sell
-61,400
Closed -$2.6M – 6713
2021
Q2 		$2.6M Hold
61,400
– – ﹤0.01% 3606
2021
Q1 		$2.91M Buy
+61,400
New +$3.65M ﹤0.01% 3420
2020
Q4 		– Sell
-27,200
Closed -$1.29M – 5867
2020
Q3 		$1.29M Buy
+27,200
New +$1.34M ﹤0.01% 3501
2020
Q2 		– Sell
-17,200
Closed -$767K – 5625
2020
Q1 		$767K Buy
+17,200
New +$866K ﹤0.01% 3581
2018
Q4 		– Sell
-34,200
Closed -$1.61M – 5884
2018
Q3 		$1.61M Buy
+34,200
New +$1.42M ﹤0.01% 3612
2018
Q2 		– Sell
-45,000
Closed -$1.22M – 5659
2018
Q1 		$1.22M Sell
45,000
-15,000
-25% -$380K ﹤0.01% 3565
2017
Q4 		$1M Buy
+60,000
New +$1.02M ﹤0.01% 3734
2015
Q2 		– Sell
-10,000
Closed -$609K – 4142
2015
Q1 		$609K Buy
+10,000
New +$610K ﹤0.01% 3457

Other funds holding PTCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

JP Morgan Chase's PTCT Position: Q1 2026 in Review

JP Morgan Chase reduced its PTC Therapeutics (PTCT) stake by 2.8% in Q1 2026, selling an estimated $710K and leaving 346,017 shares worth $22.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1975.

JP Morgan Chase first reported a position in PTCT in Q3 2014 and has held it in 44 quarters since. The position peaked at $42.1M in Q1 2023. 350 funds tracked by Wall St. Rank hold PTCT as of Q1 2026.

  • JP Morgan Chase held 346,017 shares of PTC Therapeutics worth $22.7M as of Q1 2026.
  • JP Morgan Chase sold 10,024 PTC Therapeutics shares in Q1 2026, an estimated $710K.
  • PTC Therapeutics made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #1975 holding.
  • JP Morgan Chase first reported a position in PTC Therapeutics in Q3 2014 and has held it in 44 quarters since.
  • JP Morgan Chase's PTC Therapeutics position peaked at $42.1M in Q1 2023.
  • 350 funds tracked by Wall St. Rank held PTC Therapeutics as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.